These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tamoxifen in cancer therapy: minireview. Novotny L; Rauko P; Vachálková A; Peterson-Biggs M Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680 [TBL] [Abstract][Full Text] [Related]
3. Should you be taking tamoxifen? Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691 [No Abstract] [Full Text] [Related]
4. Chemoprevention of breast cancer: recommendations and rationale. Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459 [No Abstract] [Full Text] [Related]
5. [Uterine pathology in women with breast cancer treated with tamoxifen]. Carcangiu ML Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417 [No Abstract] [Full Text] [Related]
6. Should tamoxifen users be screened for endometrial lesions? Neven P; Vergote I Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866 [No Abstract] [Full Text] [Related]
7. Tamoxifen therapy--long-term results and complications. Moore MP; Kinne DW Adv Surg; 1996; 29():263-9. PubMed ID: 8720007 [No Abstract] [Full Text] [Related]
8. One step forward or one step back with tamoxifen? Gelmon K Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885 [No Abstract] [Full Text] [Related]
9. Gynaecological aspects of tamoxifen treatment in breast cancer patients. Obwegeser R; Auerbach L; Kubista E Cancer Treat Rev; 1997; 23(5-6):289-304. PubMed ID: 9465881 [No Abstract] [Full Text] [Related]
10. [Tamoxifen and breast cancer: is everything known already?]. Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686 [No Abstract] [Full Text] [Related]
12. Tamoxifen's impact on the management of breast cancer: patient perspectives. Reichman BS Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):55-8. PubMed ID: 9065929 [TBL] [Abstract][Full Text] [Related]
13. Tamoxifen in early breast cancer. Saibara T; Ogawa Y; Onishi S Lancet; 1998 Aug; 352(9125):404. PubMed ID: 9717954 [No Abstract] [Full Text] [Related]
14. Tamoxifen and menopausal status: risks and benefits. Sasco AJ Lancet; 1996 Mar; 347(9003):761. PubMed ID: 8602018 [No Abstract] [Full Text] [Related]
15. Tamoxifen debate hinges on whose risk is high enough. Reynolds T J Natl Cancer Inst; 1998 Oct; 90(19):1428-30. PubMed ID: 9776407 [No Abstract] [Full Text] [Related]
16. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence. Litsas G Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176 [TBL] [Abstract][Full Text] [Related]
17. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma]. Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886 [TBL] [Abstract][Full Text] [Related]
19. Second cancers after adjuvant tamoxifen therapy for breast cancer. Curtis RE; Boice JD; Shriner DA; Hankey BF; Fraumeni JF J Natl Cancer Inst; 1996 Jun; 88(12):832-4. PubMed ID: 8637050 [No Abstract] [Full Text] [Related]
20. Tamoxifen. To take or not to take. That is the question. Blanchard P Tex Nurs; 1999 Aug; 73(7):4-5, 7. PubMed ID: 11949057 [No Abstract] [Full Text] [Related] [Next] [New Search]